Welcome to Critical MassLaw.com’s weekly briefing for class action and mass tort attorneys. Jury selection begins today in a closely watched opioid trial, despite several last-ditch efforts to avoid it. An $8 billion Risperdal verdict notwithstanding, Johnson & Johnson is having a really good month in talcum powder cases. Find out who’s repping DSW Shoe Warehouse in a closet full of TCPA class actions.

Feel free to reach out to me with your input. You can email me at [email protected], or follow me on Twitter@abronstadlaw

An October Surprise for the Opioid Trial?

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]